Intellectual Property Rights, Drug Access and the Doha Round

Intellectual Property Rights, Drug Access and the Doha Round

  • Case
  • Teaching Notes

This case study follows the negotiations in the World Trade Organization's Doha Round over drug access. The poorest states in the international community argued that the human suffering caused by diseases like HIV/AIDS and malaria required changes to trade rules. The WTO Trade-Related Aspects of Intellectual Property Rights agreement mandated global protection of intellectual property rights for pharmaceutical products beginning in 2005, but the poorest states insisted on revisions that would allow them to manufacture or import generic versions of life-saving drugs. The resulting impasse, as the study explains, blocked these changes and threatened to rupture the Doha Round trade talks more broadly.

You are not authorized to view Teaching Notes. Please contact your librarian for access or sign in to your existing instructor profile.
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles